Top compounds associated with response to TIGD2


Feature Type Standardized
Nominal ANOVA
mRNA FH535 GDSC1000 pan-cancer AAC -0.14 3e-05
mRNA Erlotinib gCSI pan-cancer AAC 0.19 0.0005
mRNA T0901317 GDSC1000 pan-cancer AAC -0.11 0.0006
mRNA ATRA CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA Zebularine CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Salubrinal GDSC1000 pan-cancer AAC -0.15 0.003
mRNA Parthenolide GDSC1000 pan-cancer AAC -0.15 0.004
mRNA phenformin GDSC1000 pan-cancer AAC -0.088 0.005
mRNA ZG-10 GDSC1000 pan-cancer AAC -0.13 0.005
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.1 0.005
Download CSV